Skip to main content
Clinical Trials/NL-OMON23282
NL-OMON23282
Recruiting
Not Applicable

Glycaemic control and diabetes treatment in patients with type 2 diabetes who are treated with curative intent for colorectal- or breast cancer

Diabetes Kenniscentrum Zwolle0 sites156 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 diabetes (T2DM)Breast cancer/borstkankerColorectal cancer/colorectale kankerHypertension/hypertensieDyslipidemia/dyslipidemie
Sponsor
Diabetes Kenniscentrum Zwolle
Enrollment
156
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Diabetes Kenniscentrum Zwolle

Eligibility Criteria

Inclusion Criteria

  • Patients with type 2 diabetes treated in primary care, who are diagnosed with primary breast\- or colorectal cancer, between 1999 and 2012 and who are treated with curative intent. Curative intent for breast cancer was defined as stage 1 to 3 breast cancer or ductal carcinoma in situ (DCIS) of the breast. Curative intent for colorectal cancer was defined as stage 1 to 3, who received at least surgical treatment.

Exclusion Criteria

  • Patients with evidence of relapse, patients with other cancers than breast or colorectal cancer, or patients with a history of other cancers prior to breast or colorectal cancer with the exception for non\-melanoma skin cancer and patients who received no cancer treatment or only hormone treatment in breast cancer are excluded. Patients without at least 1 year of follow\-up in the ZODIAC study prior to the diagnosis of breast or colorectal cancer are also excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials